Patents by Inventor Mathias LABS

Mathias LABS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12116581
    Abstract: The present invention relates to the targeted regulation of gene expression and more specifically to synthetic transcription factors (STFs) comprising at least one highly target specific engineered recognition domain and further comprising at least one activation or silencing domain to modulate the expression of a gene of interest, preferably to modulate the transcription of a morphogenic gene of a eukaryote. Further disclosed are methods using the STFs to enhance transformation frequencies, to optimize successful genome editing approaches, to provide haploid or double haploid organisms, and/or to provide compositions suitable for general transformation, but also for breeding purposes.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: October 15, 2024
    Assignee: KWS SAAT SE & CO. KGaA
    Inventors: Aaron Hummel, Mathias Labs
  • Publication number: 20210230616
    Abstract: The present invention relates to methods for targeted editing in a plant, a plant cell or material, which is combined with the parallel introduction of a phenotypically selectable trait. Furthermore, methods are provided not comprising a step of introducing a transgenic selection marker sequence.
    Type: Application
    Filed: May 7, 2018
    Publication date: July 29, 2021
    Applicant: INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY, CHINESE ACADEMY OF SCIENCES
    Inventors: Caixia GAO, Rui ZHANG, Jinxing LIU, Aaron HUMMEL, Zarir VAGHCHHIPAWALA, Mathias LABS
  • Publication number: 20210071189
    Abstract: The present invention relates to the targeted regulation of gene expression and more specifically to synthetic transcription factors (STFs) comprising at least one highly target specific engineered recognition domain based on a CRISPR/Cpf1 system and further comprising at least one activation or silencing domain to modulate the expression of a gene of interest, preferably to modulate the transcription of a morphogenic gene of a eukaryote, in particular a plant. Further disclosed are methods using the STFs to enhance transformation frequencies, to optimize successful genome editing approaches, to provide haploid or double haploid organisms, and/or to provide compositions suitable for general transformation, but also for breeding purposes.
    Type: Application
    Filed: December 21, 2018
    Publication date: March 11, 2021
    Applicant: KWS SAAT SE & CO. KGaA
    Inventors: Mathias LABS, Aaron HUMMEL, Yu MEI
  • Publication number: 20200332307
    Abstract: The present invention relates to the targeted regulation of gene expression and more specifically to synthetic transcription factors (STFs) comprising at least one highly target specific engineered recognition domain and further comprising at least one activation or silencing domain to modulate the expression of a gene of interest, preferably to modulate the transcription of a morphogenic gene of a eukaryote. Further disclosed are methods using the STFs to enhance transformation frequencies, to optimize successful genome editing approaches, to provide haploid or double haploid organisms, and/or to provide compositions suitable for general transformation, but also for breeding purposes.
    Type: Application
    Filed: December 21, 2018
    Publication date: October 22, 2020
    Applicant: KWS SAAT SE & CO. KGaA
    Inventors: Aaron HUMMEL, Mathias LABS
  • Publication number: 20190352626
    Abstract: The present invention relates to artificial molecular complexes comprising at least one site-specific nuclease and directly in interacting therewith at least one repair template docking domain, said repair template docking domain interacting with at least one repair template nucleic acid sequence. The artificial complex can further comprise at least one interaction domain. The artificial molecular complexes are configured to mediate repair of a DNA target sequence in a prokaryotic or eukaryotic organism with high precision in a targeted way and can thus be used for genome engineering in a prokaryotic or a eukaryotic cell or organism, or editing of a viral genome. Further provided are methods of modifying at least one DNA target sequence in a prokaryotic or eukaryotic cell or a viral genome, e.g., for trait development, or for treating a disease.
    Type: Application
    Filed: January 30, 2018
    Publication date: November 21, 2019
    Applicant: KWS SAAT SE & Co. KGaA
    Inventor: Mathias LABS